Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Hemorrhage × N(4)-oleylcytosine arabinoside × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1 Classical hematology 1

Conditions

Venous Thromboembolism 1 Thrombocythemia, Essential 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Hemorrhage 1

Interventions

Tranexamic Acid 5 Sodium Chloride 2 Saline Solution 2 bemiparin 1 Solutions 1 Proton Pump Inhibitors 1 N(4)-oleylcytosine arabinoside 1 Misoprostol 1 Lansoprazole 1 Injections, Intravenous 1 Goserelin 1 Gonadotropin-Releasing Hormone 1 Fibrin Tissue Adhesive 1 Diathermy 1 Aspirin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05198960 2025-02-04

AVAJAK

University Hospital, Brest

Phase 3 Recruiting

Classical hematologyMyeloid

Hemorrhage, Polycythemia Vera, Thrombocythemia, Essential, Venous Thromboembolism, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡